White Paper:
Rethinking Progress in Endometriosis Treatment
Endometriosis continues to pose a major clinical and scientific challenge—affecting millions worldwide yet still marked by late diagnoses, limited treatment options, and persistent misconceptions. While its underlying mechanisms span hormonal, immune, and genetic factors, therapeutic innovation has lagged behind. Here, we explore why current approaches fall short and how advanced preclinical platforms are enabling a more targeted, translational path forward.
Read the white paper to learn:
- Why endometriosis remains so difficult to diagnose and treat effectively
- The molecular and immunological drivers that sustain chronic lesions
- The limitations of current hormonal and surgical treatments
- How new models are replicating human disease faithfully
- Opportunities for mechanism-based drug discovery and precision intervention
If you are interested in endometriosis preclinical development, please reach out to us and request an exploratory conversation.
